Entering 2020, we have the opportunity to take a moment, look back and reflect on the lessons learned of the previous decade with regard to biosimilars. The road to a successful biosimilars market has been anything but straightforward.
At a recent business meeting, I had breakfast with a man and we talked about work. When I explained my work on the opioid crisis, he shared his story of struggling to stop taking opioids following a routine joint replacement surgery.
Physicians and clinicians are always looking for innovative products and solutions that can help them improve the quality of outcomes and patient experience. From large capital and construction solutions to implantable cardiology and orthopedic devices, the Vizient Innovative Technology Exchange offers insight into products that will shape the service lines of tomorrow as well as solve the challenges of today for health systems and clinicians.
This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.